Literature DB >> 26759162

Effects of Senegenin against hypoxia/reoxygenation-induced injury in PC12 cells.

Xiao-Qing Zhu1,2, Xue-Min Li1,3, Yan-Dong Zhao1, Xi-Luan Ji1, Yan-Ping Wang1, Yong-Mei Fu1, Hua-Dong Wang1, Da-Xiang Lu1, Ren-Bin Qi4.   

Abstract

OBJECTIVE: To investigate the effect and the potential mechanism of Senegenin (Sen) against injury induced by hypoxia/reoxygenation (H/R) in highly differentiated PC12 cells.
METHODS: The cultured PC12 cells were treated with H/R in the presence or absence of Sen (60 μmol/L). Four groups were included in the experiment: control group, H/R group, H/R+Sen group and Sen group. Cell viability of each group and the level of lactate dehydrogenase (LDH) in culture medium were detected for the pharmacological effect of Sen. Hoechst 33258 staining and annexin V/propidium iodide double staining were used to analyze the apoptosis rate. Moreover, mitochondrial membrane potential (△Ψm), reactive oxygen species (ROS) and intracellular free calcium ([Ca(2+)]i) were measured by fluorescent staining and flow cytometry. Cleaved caspase-3 and activity of NADPH oxidase (NOX) were determined by colorimetric protease assay and enzyme linked immunosorbent assay, respectively.
RESULTS: Sen significantly elevated cell viability (P<0.05), decreased the leakage of LDH (P<0.05) and apoptosis rate (P<0.05) in H/R-injured PC12 cells. Sen maintained the value of △Ψm (P<0.05) and suppressed the activity of caspase-3 (P<0.05). Moreover, Sen reduced ROS accumulation P<0.05) and [Ca(2+)]i increment (P<0.05) by inhibiting the activity of NOX (P<0.05).
CONCLUSION: Sen may exert cytoprotection against H/R injury by decreasing the levels of intracellular ROS and [Ca(2+)]i, thereby suppressing the mitochondrial pathway of cellular apoptosis.

Entities:  

Keywords:  NAPDH oxidase; PC12 cells; hypoxia/reoxygenation; reactive oxygen species; senegenin

Mesh:

Substances:

Year:  2016        PMID: 26759162     DOI: 10.1007/s11655-015-2091-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  28 in total

1.  Cadmium induces intracellular Ca2+- and H2O2-dependent apoptosis through JNK- and p53-mediated pathways in skin epidermal cell line.

Authors:  Young-Ok Son; Jeong-Chae Lee; J Andrew Hitron; Jingju Pan; Zhuo Zhang; Xianglin Shi
Journal:  Toxicol Sci       Date:  2009-11-03       Impact factor: 4.849

2.  Glibenclamide ameliorates ischemia-reperfusion injury via modulating oxidative stress and inflammatory mediators in the rat hippocampus.

Authors:  Dalaal M Abdallah; Noha N Nassar; Rania M Abd-El-Salam
Journal:  Brain Res       Date:  2011-03-05       Impact factor: 3.252

3.  A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis.

Authors:  R Cursio; J Gugenheim; J E Ricci; D Crenesse; P Rostagno; L Maulon; M C Saint-Paul; B Ferrua; A P Auberger
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

Review 4.  Bioenergetic aspects of apoptosis, necrosis and mitoptosis.

Authors:  V P Skulachev
Journal:  Apoptosis       Date:  2006-04       Impact factor: 4.677

5.  BT-11 is effective for enhancing cognitive functions in the elderly humans.

Authors:  Ki Young Shin; Jun-Young Lee; Beom Young Won; Hee Yeon Jung; Keun-A Chang; Sushruta Koppula; Yoo-Hun Suh
Journal:  Neurosci Lett       Date:  2009-08-20       Impact factor: 3.046

Review 6.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

7.  Cadmium inhibits the electron transfer chain and induces reactive oxygen species.

Authors:  Yudong Wang; Jing Fang; Stephen S Leonard; K Murali Krishna Rao
Journal:  Free Radic Biol Med       Date:  2004-06-01       Impact factor: 7.376

8.  Acetaminophen reduces mitochondrial dysfunction during early cerebral postischemic reperfusion in rats.

Authors:  Sunanda S Baliga; Kathryn M Jaques-Robinson; Norell M Hadzimichalis; Roseli Golfetti; Gary F Merrill
Journal:  Brain Res       Date:  2010-01-14       Impact factor: 3.252

9.  Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury.

Authors:  Ben S Rayner; T T Hong Duong; Simon J Myers; Paul K Witting
Journal:  J Neurochem       Date:  2006-03-08       Impact factor: 5.372

10.  Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats.

Authors:  Weibin Xie; Yan Yang; Xiaoping Gu; Yaguo Zheng; Yu-e Sun; Ying Liang; Jinhua Bo; Zhengliang Ma
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

View more
  5 in total

1.  Senegenin Inhibits Hypoxia/Reoxygenation-Induced Neuronal Apoptosis by Upregulating RhoGDIα.

Authors:  Xuemin Li; Yandong Zhao; Panhong Liu; Xiaoqing Zhu; Minyi Chen; Huadong Wang; Daxiang Lu; Renbin Qi
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia.

Authors:  Zhe Chen; Yu Yang; Ying Han; Xijun Wang
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

3.  Senegenin Rescues PC12 Cells with Oxidative Damage Through Inhibition of Ferroptosis.

Authors:  Heping Zhang; Wei Zhou; Jianling Li; Zhaohui Qiu; Xiaotong Wang; Hui Xu; Huadong Wang; Daxiang Lu; Renbin Qi
Journal:  Mol Neurobiol       Date:  2022-09-07       Impact factor: 5.682

Review 4.  Polygala tenuifolia: a source for anti-Alzheimer's disease drugs.

Authors:  Xinxin Deng; Shipeng Zhao; Xinqi Liu; Lu Han; Ruizhou Wang; Huifeng Hao; Yanna Jiao; Shuyan Han; Changcai Bai
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

5.  Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway.

Authors:  Xing Ren; Jiwei Zhang; Yunnan Zhao; Lingzhi Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-04       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.